Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 29;136(18):2018-2026.
doi: 10.1182/blood.2019004118.

Hepatosplenic T-cell lymphoma: a rare but challenging entity

Affiliations
Review

Hepatosplenic T-cell lymphoma: a rare but challenging entity

Barbara Pro et al. Blood. .

Abstract

Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemotherapy regimens. Approximately 20% of the cases arise in the background of chronic immunosuppression or immune dysregulation. Patients commonly present with constitutional symptoms, hepatic and liver enlargement, and cytopenias; hematophagocytic syndrome can also occur. The most frequent chromosomal aberrations associated with HSTCL are isochromosome 7q and trisomy 8, and most cases harbor mutations in genes involved in chromatin modification or the JAK/STAT pathway. The rarity of this disease, along with lack of nodal involvement and presenting symptoms that mimic different entities including infectious etiologies, makes this lymphoma a significant diagnostic challenge. In this review, we highlight the clinical and pathologic features of HSTCL. Moreover, we summarize the results of recent molecular studies suggesting potential targets for novel therapeutics strategies.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Morphologic features of different cases of HSTCL. (A) Spleen involvement with sheets of small neoplastic lymphoid cells involving cords and sinuses of spleen (hematoxylin and eosin [H&E] stain; original magnification ×600). (B) Bone marrow aspirate in a patient with progressive HSTCL (Wright-Giemsa stain; original magnification ×1000). The neoplastic T cells in this case (highlighted with thin tall arrows) are medium sized and demonstrate fine chromatic, resembling blasts. A rare neoplastic cell is demonstrating hemophagocytosis (highlighted with a thick short arrow). (C) Bone marrow core biopsy showing sinusoidal expansion by medium-sized lymphoid cells (H&E stain; original magnification ×600). (D) CD3 immunohistochemical stain in bone marrow core biopsy, highlighting the sinusoidal expansion by neoplastic T cells (original magnification ×1000).

References

    1. Harris NL, Jaffe ES, Stein H, et al. . A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361-1392. - PubMed
    1. Farcet JP, Gaulard P, Marolleau JP, et al. . Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75(11):2213-2219. - PubMed
    1. Gaulard P, Jaffe ES, Krenacs L, Macon WR. Hepatosplenic T-cell lymphoma In: Swerdlow SH, Campo E, Harris NL, eds., et al... WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Lyon, France: International Agency for Research on Cancer; 2017:381-382.
    1. Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project . International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-4130. - PubMed
    1. Foss FM, Horwitz SM, Civallero M, et al. . Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas. Am J Hematol. 2020;95(2):151-155. - PMC - PubMed